Expertise in
15
conditions

Duk-woo Y. Park

Seoul, KR 
Expertise in
15
conditions
Seoul, KR 
OverviewLocationsClinical Research

Overview

Duk-woo Park practices in Seoul, Republic of Korea. Park is highly rated in 15 conditions, according to our data. Their top areas of expertise are Coronary Heart Disease, Heart Attack, Stable Angina, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Their clinical research consists of co-authoring 411 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Seoul, Republic of Korea
Other Locations
Gangneung, Republic of Korea
Ulsan, Republic of Korea
Seoul St. Mary's Hospital, Eunpyeong St. Mary's Hospital, St. Vincent's Hospital, Yangsan, Republic of Korea
Yeouido St. Mary's Hospital, St. Vincent's Hospital, Suwon, Republic of Korea
Songnam, Republic of Korea
Gyeonggi-do, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: June 06, 2025
Intervention Type: Drug
Study Drugs: Tailored antithrombotic strategy, Conventional antithrombotic strategy
Study Phase: Phase 4
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: December 20, 2023
Intervention Type: Device
Evaluation of Effectiveness and Safety of Ultimaster® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Ultimaster® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2023
Intervention Type: Device
Transcatheter Mitral Valvuloplasty for Severe Mitral Regurgitation Pilot Study
Transcatheter Mitral Valvuloplasty for Severe Mitral Regurgitation Pilot Study
Enrollment Status: Completed
Publish Date: February 24, 2022
Intervention Type: Device
a Multicenter, Randomized, Open-label, Active-treatment, Controlled Trial to Compare the Efficacy of NOAC With Edoxaban vs. Dual Antiplatelet Therapy (DAPT) for Prevention of Leaflet Thrombosis (Documented by Cardiac CT Imaging) and Cerebral Embolization (Documented With Brain DW-MRI Imaging) in Patients Without an Absolute Indication for Chronic OAC After Successful TAVR
a Multicenter, Randomized, Open-label, Active-treatment, Controlled Trial to Compare the Efficacy of NOAC With Edoxaban vs. Dual Antiplatelet Therapy (DAPT) for Prevention of Leaflet Thrombosis (Documented by Cardiac CT Imaging) and Cerebral Embolization (Documented With Brain DW-MRI Imaging) in Patients Without an Absolute Indication for Chronic OAC After Successful TAVR
Enrollment Status: Completed
Publish Date: November 08, 2021
Intervention Type: Drug
Study Drugs: NOAC, DAPT
Study Phase: Phase 4
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Acute Myocardial Infarction; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Acute Myocardial Infarction; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: September 13, 2021
Intervention Type: Device
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
Enrollment Status: Terminated
Publish Date: December 15, 2017
Intervention Type: Device
Study Phase: Phase 4
View 6 Less Clinical Trials

411 Total Publications

Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial.
Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: May 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Park's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile